WO2005007083A3 - Chemical compounds - Google Patents

Chemical compounds Download PDF

Info

Publication number
WO2005007083A3
WO2005007083A3 PCT/US2004/019410 US2004019410W WO2005007083A3 WO 2005007083 A3 WO2005007083 A3 WO 2005007083A3 US 2004019410 W US2004019410 W US 2004019410W WO 2005007083 A3 WO2005007083 A3 WO 2005007083A3
Authority
WO
WIPO (PCT)
Prior art keywords
chemical compounds
compositions
medicaments
thienopyrimidine derivatives
compounds
Prior art date
Application number
PCT/US2004/019410
Other languages
French (fr)
Other versions
WO2005007083A2 (en
Inventor
Scott Howard Dickerson
Holly Kathleen Emerson
Kevin Wayne Hinkle
Keith Robert Hornberger
Douglas Mccord Sammond
Stephon Smith
Kirk Lawrence Stevens
Robert Dale Hubbard
Kimberly Glennon Petrov
Michael John Reno
David Edward Uehling
Alex Gregory Waterson
Original Assignee
Smithkline Beecham Corp
Scott Howard Dickerson
Holly Kathleen Emerson
Kevin Wayne Hinkle
Keith Robert Hornberger
Douglas Mccord Sammond
Stephon Smith
Kirk Lawrence Stevens
Robert Dale Hubbard
Kimberly Glennon Petrov
Michael John Reno
David Edward Uehling
Alex Gregory Waterson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Scott Howard Dickerson, Holly Kathleen Emerson, Kevin Wayne Hinkle, Keith Robert Hornberger, Douglas Mccord Sammond, Stephon Smith, Kirk Lawrence Stevens, Robert Dale Hubbard, Kimberly Glennon Petrov, Michael John Reno, David Edward Uehling, Alex Gregory Waterson filed Critical Smithkline Beecham Corp
Publication of WO2005007083A2 publication Critical patent/WO2005007083A2/en
Publication of WO2005007083A3 publication Critical patent/WO2005007083A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention discloses thienopyrimidine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such thienopyrimidine derivatives are useful in the treatment of diseases associated with inappropriate ErbB family kinase activity.
PCT/US2004/019410 2003-06-18 2004-06-17 Chemical compounds WO2005007083A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47932403P 2003-06-18 2003-06-18
US60/479,324 2003-06-18

Publications (2)

Publication Number Publication Date
WO2005007083A2 WO2005007083A2 (en) 2005-01-27
WO2005007083A3 true WO2005007083A3 (en) 2005-04-21

Family

ID=34079044

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/019410 WO2005007083A2 (en) 2003-06-18 2004-06-17 Chemical compounds

Country Status (1)

Country Link
WO (1) WO2005007083A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8648087B2 (en) * 2005-11-15 2014-02-11 Array Biopharma, Inc. N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
AR060631A1 (en) * 2006-04-26 2008-07-02 Piramed Ltd DERIVATIVES OF PIRIMIDINE AND ITS USE AS INHIBITORS OF PHOSFATIDYLNOSITOL 3-QUINASE (PI3K)
PL2024372T3 (en) * 2006-04-26 2010-11-30 Hoffmann La Roche Thieno[3,2-d]pyrimidine derivative useful as pi3k inhibitor
WO2009100536A1 (en) * 2008-02-15 2009-08-20 Methylgene Inc. Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures
TWI565709B (en) 2011-07-19 2017-01-11 英菲尼提製藥股份有限公司 Heterocyclic compounds and uses thereof
EP3023101B1 (en) 2013-07-18 2020-08-19 Taiho Pharmaceutical Co., Ltd. Therapeutic agent for fgfr inhibitor-resistant cancer
TR201907147T4 (en) 2013-07-18 2019-06-21 Taiho Pharmaceutical Co Ltd Anti-tumor drug for intermittent administration of the Fgfr inhibitor.
PE20221581A1 (en) * 2019-12-12 2022-10-06 Ptc Therapeutics Inc COMPOUNDS TO TREAT FAMILY DYSAUTONOMY
CN115304541B (en) * 2022-08-26 2024-03-05 上海药坦药物研究开发有限公司 Preparation method of 3-chloro-4- (2-pyridylmethoxy) aniline

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053446A1 (en) * 2001-12-19 2003-07-03 Smithkline Beecham Corporation Thienopyrimidine compounds as protein tyrosine kinase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053446A1 (en) * 2001-12-19 2003-07-03 Smithkline Beecham Corporation Thienopyrimidine compounds as protein tyrosine kinase inhibitors

Also Published As

Publication number Publication date
WO2005007083A2 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
WO2004112719A8 (en) Chemical compounds
WO2004084813A3 (en) Chemical compounds
IL173348A (en) Thienopyridine compounds, pharmaceutical compositions comprising same and use thereof in the preparation of medicaments
WO2003049702A8 (en) Vanilloid receptor ligands and their use in treatments
WO2006044753A3 (en) Chemical compounds
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2005049581A8 (en) Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
WO2002102793A3 (en) Quinazolinediones as antibacterial agents
WO2004006858A3 (en) Compounds, compositions, and methods employing same
ZA200506422B (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
WO2002048147A3 (en) Pyrazolopyridines
WO2003029209A3 (en) Chemical compounds
WO2003013541A8 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
AU2003228770A1 (en) Substituted pyrazolopyrimidines
WO2003000699A8 (en) Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
WO2004026836A8 (en) 1-pyridin-4-yl-urea derivatives
MXPA05011076A (en) Chemical compounds.
WO2005040171A8 (en) Pyrazolo and imidazo-pyrimidine derivatives
WO2005023815A3 (en) Neuroprotective bicyclic compounds and methods for their use
WO2006023843A3 (en) Novel heterocycles
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
TW200505452A (en) Chemical compounds
WO2005055939A3 (en) Vinca derivatives
WO2005007083A3 (en) Chemical compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase